Whether you’ll be at PHA 2022 in Atlanta or you’re taking action from home, help us keep the momentum going on the Safe Step Act (S. 464, H.R. 2163). The legislation would limit insurance companies’ step-therapy requirements by providing exceptions for people with high-risk conditions such as PH.

Step therapy or “fail first” requirements force patients to try cheaper medications that don’t work as effectively as those their doctors initially prescribed.

The Pulmonary Hypertension Association aims to send 500 messages to Congress about the Safe Step Act during PHA 2022 International PH Conference and Scientific Sessions.

Help us make our goal. Tell your legislators the PH community can’t wait on the Safe Step Act and ask them to pass it this year.